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ABSTRACT
Background: Daily activity is a potentially important
measure for assessing prognosis in individuals with
chronic heart failure (CHF), and few studies have
investigated the prognostic value of daily activity
measurement. The present study sought to determine
whether there is an association between daily activity
and mortality/mean life expectancy as predicted by
the Seattle Heart Failure Model (SHFM), and to provide an estimate of the anchor-based minimum clinically important difference (MCID) for daily activity
measured by single-axis accelerometers in implanted
cardiac defibrillators. Methods: This study utilized a
retrospective chart review of 102 medical records of
patients with CHF and Medtronic® implanted cardiac defibrillators (ICDs). Mean daily activity was
calculated for a two week period prior to both a baseline and follow-up routine clinical visit. Clinical characteristics from the baseline clinic visit were used for
calculating SHFM estimates of mean life expectancy,
1-year mortality, and 5-year mortality. A five-point
global rating scale was scored based on documented
clinician impression, patient self-report, and laboratory and cardiographic tests for determining the
MCID. Results: There was a moderate correlation between baseline daily activity and each of the SHFM
prognostic indicators: 1-year mortality (r = 0.36, p <
0.001, 5-year mortality (r = 0.40, p < 0.001), and life
expectancy (r = 0.43, p < 0.001). The MCID for a decline in daily activity was approximately 0.5 hours
and was approximately 1.0 hours for improvement in
daily activity. Conclusions: Although previous research has established the short-term predictive value
of ICD-measured daily activity for CHF-related clinical events, no prior study has examined the longer*
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term prognostic value of ICD-based daily activity.
The results of the present study suggest that low daily
activity, as recorded by ICDs in patients with CHF,
should prompt a more formal evaluation of prognosis
using the SHFM. Furthermore, changes of 0.5 to 1.0
hours of activity per day appear to be clinically meaningful.
Keywords: Heart Failure; Daily Activity; Prognosis;
Cardiac Defibrillator

1. INTRODUCTION
Individuals with chronic heart failure (CHF) are characterized by reduced daily physical activity, which is believed to contribute to a cycle of inactivity and deconditioning [1-9] and to reductions in exercise tolerance following the cessation of an exercise program [10,11]. Although daily activity has been used as an endpoint in
several intervention-based studies [7,10-14], little data
exists about the prognostic value of daily activity in heart
failure. Walsh et al. [15] found that daily activity, measured using a pedometer dichotomized at 250 × 102 steps
per week, was an independent predictor of mortality in a
multivariate analysis of 84 subjects with CHF. More recently (2010), in a sample of 60 subjects with CHF,
Howell et al. [16] reported that subjects with a peak daily
activity level of less than 22 metabolic equivalents per
minute (measured using actigraphy) had lower 11-month,
event-free survival. The devices used to measure daily
activity in the aforementioned studies, however, are external devices that depend on subjects’ adherence, and
neither study provided data regarding the amount of
change in daily activity that is considered to be clinically
meaningful. The single-axis accelerometers in implanted
cardiac defibrillators (ICDs) avoid the potential problems
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of subject non-adherence and selection bias in studies
examining daily activity in patients with CHF. No prior
study has investigated whether this implanted devicebased measure of daily activity is associated with life
expectancy and mortality, nor has any prior study investigated what amount of change in this measure is considered to be clinically meaningful. These are the primary
aims of the present study.
Medtronic® ICDs (Medtronic, Minneapolis, MN) contain a single-axis accelerometer that, on a minute-tominute basis, determines whether patient activity exceeded an equivalent of 70 - 80 steps/minute. The device
then records the number of minutes of activity on a daily
basis, which is stored for a rolling 14 month period [17].
Among the various methods for measuring daily activity,
including questionnaires, measurement of energy expenditure, and external accelerometers [18], ICD-based daily
activity measures are not limited by short monitoring
periods, monitor wearing non-adherence, and patient recollection. Despite these advantages, few studies have
utilized this measure [19-21].
The daily activity data recorded by Medtronic® implanted ICDs (labeled “patient activity” by Medtronic®)
have been examined in three studies. Gulati et al. [19]
found that the six-minute walk test (6MWT) and daily
activity measured within the preceding or subsequent 24
hours of conducting the test were moderately correlated
(r = 0.42 and 0.49, respectively). Despite their findings
of only moderate correlation, the authors concluded that
daily activity may be considered a surrogate for the 6
MWT. Both Adamson et al. [20] and Small et al. [21]
considered daily activity among a variety of devicebased parameters for predicting hospitalization for acute
decompensated heart failure. Only Adamson et al. [20]
found that a decline in daily activity was a statistically
significant predictor, with a decline of 0.4 hours per day
in activity between baseline and time of hospitalization.
Daily activity may not have been a significant predictor
in the analysis by Small et al. [21] because they dichotomized daily activity at 0.5 hours per day. No prior
study has investigated the amount of change in ICDmeasured daily activity that is considered to be clinically
meaningful.
The minimum clinically important difference (MCID)
is the smallest change that a patient would perceive as
beneficial, and when considering a decline in the measure of interest, would indicate the need for a change in
treatment [22,23]. Calculation of the MCID includes distribution-based and anchor-based methods [23]. Distribution-based methods include calculation of an effect
size which provides a ratio of change in an outcome to
the baseline standard deviation of that measure for interpreting whether the effect observed in a given trial was
statistically significant, while anchor-based methods deCopyright © 2012 SciRes.

termine the mean amount of change associated with perceived level of change using the Global Rating of Change
Scale (GRS). The anchor-based MCID can utilize either
a patient-based or clinician-based anchor [25]. A clinician-based anchor in addition to other objective clinical
data may be more appropriate for judging change in disease status [24].
The only two studies to report on the relationships
between daily activity and prognosis in individuals with
CHF were longitudinal studies that measured mortality
directly [15,16]. Howell et al. [16] followed subjects for
up to one year and Walsh et al. [15] up to five years. Although direct measurement of mortality is ideal, it is difficult to study design to implement. The Seattle Heart
Failure Model (SHFM) is a multivariate risk model developed based on data from six published pharmacologic
intervention clinical trials representing nearly 11,000
patients with systolic heart failure [24]. The model predicts four primary outcomes: 1, 3, and 5-year mortality
and mean life expectancy. The 16 independent predictors
in the model include data related to patient characteristics, medications, laboratory results, and use of implanted interventional devices. No prior study has examined whether daily activity is associated with the SHFM
prognostic indicators.
In summary, daily activity is a potentially important
measure for assessing prognosis in individuals with CHF.
Further, it is not known whether daily activity is associated with the SHFM prognostic estimates and what
amount of change in daily activity is necessary to be
considered clinically meaningful. Therefore, the purpose
of the present study was two-fold: 1) To determine whether there is an association between daily activity and
mortality/mean life expectancy as predicted by the Seattle Heart Failure Model, and 2) to provide an estimate of
the anchor-based MCID for daily activity measured by
single-axis accelerometers in implanted devices.

2. METHODS
2.1. Design
Retrospective chart review of clinical data at two time
points at least three months apart between January 2008
and January 2011 in patients with Medtronic® ICDs.

2.2. Subjects
One hundred thirty-five medical records (approximately
two-thirds of available records) were randomly selected
from a list of patients with Medtronic® ICDs who were
managed by a tertiary heart failure and transplant services clinic between January 2008 and January 2011.
Medical records were included if the patient had a
Medtronic implanted device (ICD or biventricular ICD)
WJCD
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and a diagnosis of systolic heart failure with a history of
LVEF < 40%. Records were excluded if there was
insufficient data in the medical record to achieve the
study objectives described below.

2.3. Clinical Data Extraction
Clinical data representing two points in time for each
patient were extracted. Time point 1 was a clinic visit for
which daily activity data was available for the preceding
two weeks and that provided the necessary clinical and
laboratory data for the SHFM. Time point 2 was a subsequent clinic visit at least three months after time point
1 for which daily activity data was available in the preceding two weeks and had sufficient documentation for
determining whether or not there was a change in clinical
status. Extracted data included the variables required for
the SHFM, patient and clinician quotes regarding change
in clinical status between the two time points, and device-recorded daily activity.

2.4. Measurements
The anchor used to calculate the MCID was the 5-point
GRS. The GRS captured change in clinical status using
the clinician’s documented impression of the course of
the patient’s overall disease state as supported by documented patient self-report and changes in the patient’s
clinical characteristics. These clinical characteristics included left ventricular ejection fraction, New York Heart
Association (NYHA) Functional Class, B-type natriuretic peptide, hospitalization or other significant health
event, and change in CHF-related medications.
Medtronic® ICDs contain a single-axis accelerometer
that record the amount of daily activity every 24 hours
for a rolling 14-month period. The number of hours of
activity in each 24 hour period is based on the number of
minutes per day in which the patient was active at or
above an equivalent of 70 - 80 steps/min, with each minute recorded as a dichotomized value of yes/no [17].
Daily activity is plotted for a 14-month period on the
printed report generated by the Cardiac Compass® device summary. The data point included for analysis was a
visual estimate of the mean activity (hours per day) for
the 2 weeks preceding the clinic visit on which the time
point is based. Daily activity data were not measured/
extracted until after other data, including the GRS, were
collected. To ensure accuracy of visually estimating the
mean daily activity from the activity graph, two researchers independently estimated the mean daily activity for 25 separate sample cases with a range of 0 to 8
hours of activity per day. The intra-class correlation coefficient (2,1) was 0.998 (95% confidence interval 0.996
to 0.999).
The SHFM prognostic estimates for life expectancy,
Copyright © 2012 SciRes.
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1-year mortality, and 5-year mortality were calculated
using the extracted clinical data from time point 1. Three
laboratory values not routinely collected on each clinical
visit that are required for the SHFM were total cholesterol, lymphocyte percentage, and uric acid. Therefore, if
the lab value was collected within six months of the clinic visit, this value was recorded and attributed to the
baseline dataset. Using this strategy, total cholesterol and
uric acid were missing in 4 and 42 cases, respectively.
These values were imputed using the aregImpute multiple imputation function from Harrell’s Hmisc package
[26] as used by Gorodeski et al. [27] who were missing
similar data for use in the SHFM.

2.5. Data Analysis
2.5.1. Association between Daily Activity and
Mortality/Life Expectancy
The Pearson correlation coefficient was calculated for
daily activity at time point 1 (hours per day) and each of
the following predicted values derived from the SHFM:
1 year mortality (%), 5 year mortality (%), and mean life
expectancy (years).
2.5.2. Determination of the Anchor-Based MCID
Change in daily activity between time points 1 and 2 was
used to determine the anchor-based MCID for this measure. One-way analysis of variance with repeated planned
contrasts was used to compare the mean change in daily
activity for each category of the GRS to the previous one.
The mean and 95% confidence interval for change in
daily activity between time points 1 and 2 for each level
of the GRS were used to identify whether there was an
apparent threshold of change in daily activity for those
with and without change in clinical status. The magnitude of the MCID was contextualized using the NYHA
Functional Classification. Classes II and III/ IV represent
distinct symptomatic clinical presentations and have previously been shown to have statistically significantly
different aerobic capacities [28], and the difference in
daily activity between these classes may provide insight
into what amount of change in daily activity is clinically
meaningful. Therefore, daily activity for Classes II and
III/IV were compared using t-tests.

3. RESULTS
Of the 135 medical records reviewed, 33 records were
excluded due to not having at least two clinic visits and/
or not having a Cardiac Compass® report available for
extracting daily activity data. Descriptive statistics for
the overall sample of 102 included cases are presented in
Table 1. There was a moderate correlation between baseline daily activity and each of the SHFM prognostic indicators: 1-year mortality (r = 0.36, p < 0.001, 5-year
WJCD
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Table 1. Descriptive statistics.
Mean (SD)
Age

64.6 (13.3) years

Gender

30 females, 72 males

Etiology

50 ischemic, 52 nonischemic

NYHA-FC

2.0 (0.76)

LVEF

27.8 (11.5)%

Type of Device

26 ICD, 72 BiVICD

Time between Visits

7.5 (4.2) months

Daily Activity

2.6 (1.7) hours·day–1

Life Expectancy

10.1 (5.2) years

1 Year Mortality

9.4 (9.3)%

5 Year Mortality

33.0 (24.1)%

NYHA-FC = New York Heart Association Functional Class; LVEF = left
ventricular ejection fraction; ICD = implantable cardiac defibrillator; BiVICD =
biventricular implantable cardiac defibrillator.

mortality (r = 0.40, p < 0.001), and life expectancy (r =
0.43, p < 0.001). Figure 1 depicts the scatterplot for
daily activity and life expectancy.
With regard to the MCID for ICD-measured daily activity, descriptive statistics for cases stratified by GRS
are presented in Table 2. There was a statistically significant main effect of GRS on change in daily activity
[F(4,97) = 21.48, p = 0.000, ω = 0.41]. Planned contrasts
revealed statistically significant differences (p < 0.05)
between each subsequent GRS category except between
“about the same” and “a little better” (p = 0.085). Figure
2 demonstrates the mean and 95% confidence interval
for change in daily activity for each GRS category. The
MCID for a decline in daily activity is approximately 0.5
hours and is approximately 1.0 hours for improvement in
daily activity. There was a statistically significant mean
difference of 0.88 hours of baseline activity between
NYHA classes II and II/IV [2.7 (1.8) hours for those with
NYHA class II versus 1.8 (1.5) hours for those with class
III/IV, t(1,73) = 2.24, p = 0.014, effect size = 0.54].

4. DISCUSSION
Daily activity is a potentially important measure of prognosis in individuals with CHF, and no prior published
study has reported what amount of change in daily activity is considered to be clinically meaningful. The results
of the present study demonstrated that ICD-measured
daily activity was associated with disease severity as
measured by the SHFM, and changes of 0.5 and 1.0
hours of daily activity appear to represent clinically
meaningful decline and improvement, respectively.
With regard to the moderate correlation between daily
activity and the SHFM, daily activity was more strongly
associated with life expectancy than 1- and 5-year mortality, explaining 19% of the variance in calculated life
Copyright © 2012 SciRes.

Figure 1. Scatterplot of baseline daily activity versus life expectancy. r = 0.43, p < 0.001.

expectancy. Implanted device-measured daily activity
has previously been demonstrated to be a useful predictor of hospitalization for acute decompensated heart failure [20], and daily activity measured using actigraphy
and pedometers was predictive of mortality [15,16]. The
results of the present study suggest that, in addition to
consideration of other prognostic factors including the
SHFM, ICD-based measurement of daily activity may
also be clinically useful in identifying individuals with
increased risk of mortality and decreased life expectancy.
This research did not address whether an intervention to
improve daily activity would result in a change in prognosis, and this should be addressed by future research.
With regard to the MCID for daily activity, a lesser
amount of change in daily activity was associated with a
clinically meaningful decline compared to the amount of
change representing clinically meaningful improvement.
There are two potential explanations for this difference.
First, although not previously reported for daily activity,
two prior studies [29,30] found that the MCID for improvement and decline in the 6MWT in individuals with
CHF were dissimilar. Second, and perhaps more likely,
there was no statistically significant difference in daily
activity between those cases rated as “about the same”
and “a little better” because this analysis had less statistical power (effect size = 0.43, 1 – β = 0.38) than did the
analysis of those cases rated as “about the same” and “a
little worse” (effect size = 0.55, 1 – β = 0.55) due to a
smaller mean difference.
There are two considerations for contextualizing the
magnitude of these MCID estimates. First, Small et al.
[21] found a mean decline of 0.4 hours in those patients
hospitalized for acute decompensated heart failure,
which likely represents a clinically meaningful change
and is consistent with the results of the present study.
Additionally, the mean difference of 0.88 hours in the
present study between those with NYHA class II and
class III/IV, although not suggestive of a direction of
change (e.g., improvement vs. decline), also suggests
that a meaningful difference in daily activity is ≤1.0
WJCD
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Table 2. Descriptive statistics stratified by global rating scale category.

Age [years]

Much Worse
n = 10
Mean (SD)
69.8 (7.4)

A Little Worse
n = 13
Mean (SD)
62.3 (17.0)

About the Same
n = 57
Mean (SD)
64.8 (12.4)

A Little Better
n = 12
Mean (SD)
64.4 (18.4)

Much Better
n = 10
Mean (SD)
62.0 (11.4)

Gender [% male]

90.0

61.5

71.9

66.7

60.0

Etiology [% ischemic]

50.0

69.2

49.1

25.0

50.0

LVEF [%]

26.5 (10.6)

24.5 (5.3)

31.0 (12.4)*

26.3 (9.3)

17.5 (8.9)*

NYHA-FC

2.0 (0.8)

1.8 (0.6)

1.9 (0.8)

2.2 (0.7)

2.9 (0.7)

Baseline Activity
[hours·day–1]

2.6 (2.2)

2.9 (1.5)

2.7 (1.6)

2.7 (2.4)

1.9 (1.8)

Change in Activity
[hours·day–1]

–1.3 (0.7)

–0.52 (0.7)*

0.04 (0.6)*

0.4 (0.6)

1.08 (0.7)*

*one-way ANOVA repeated contrast p < 0.05 compared to previous level; LVEF = left ventricular ejection fraction, NYHA-FC = New York Heart Association
Functional Class.

Units for change in daily activity are hours per day

Figure 2. Mean and 95% confidence interval for change in daily activity stratified by global
rating scale.

hours. Other indices of clinically meaningful change for
ICD-measured daily activity should be examined in future research. For example, the minimum detectable difference (an index of test-retest reliability or measurement error), would provide an estimate of the amount of
variation in daily activity that represents background
“noise,” against which changes in daily activity could be
compared.

4.1. Limitations
There are several limitations of the present analyses.
First, the anchor used for the MCID analysis was based
on clinician impression as abstracted from clinical documentation, which was not intended for such an analysis.
However, clinician-based anchors have been reported by
some to represent a better anchor than patient perception-based anchors [25]. The present study used the clinician’s impression of change in clinical status as supported by a wide range of supporting clinical data. Second, uric acid had to be imputed in 42 cases, nearly one
third of the overall data set. However, the method used
for imputation has been previously demonstrated for in a
greater percent of cases for this variable for use in the
Copyright © 2012 SciRes.

SHFM [27]. Third, the findings of the present paper may
not be generalizable to other types and brands of cardiac
defibrillators as the measurement, processing, and reporting of activity data by other devices may be substantially different than Medtronic® devices. Fourth, not all
patient characteristics were similar when stratified according to the GRS. For example, there was a greater
proportion of males in the “much worse” group and a
lower mean LVEF in the “much better” group. The influence of the differences on the results is not clear. Finally, daily activity was measured using a visual estimate from a printed graph using a two-week sample preceding each clinical visit. Although this method demonstrated excellent inter-rater reliability, a more accurate
method for quantifying daily activity is needed. Additionally, use of longer sampling frame that allows for
characterization of the trend of daily activity (i.e., improving, declining, fluctuating, or stable) prior to calculation of the SHFM prognostic indicators may reveal a
greater prognostic value for daily activity.

4.2. Conclusion
Daily activity as recorded by ICDs in patients with CHF
WJCD
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appears to be a promising new measure for the research
and clinical settings. Low daily activity, as recorded by
ICDs in patients with CHF, should prompt a more formal
evaluation of prognosis using the SHFM. Furthermore,
changes of 0.5 to 1.0 hours of activity per day appear to
be clinically meaningful.
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